243 related articles for article (PubMed ID: 29964211)
1. Botulinum Toxin: Techniques Within Pediatric Physiatry.
Paulson A; Zigler CK; Houtrow A; Pruitt D
PM R; 2019 Jan; 11(1):38-44. PubMed ID: 29964211
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
[TBL] [Abstract][Full Text] [Related]
3. Instrumented assessment of the effect of Botulinum Toxin-A in the medial hamstrings in children with cerebral palsy.
Bar-On L; Aertbeliën E; Molenaers G; Van Campenhout A; Vandendoorent B; Nieuwenhuys A; Jaspers E; Hunaerts C; Desloovere K
Gait Posture; 2014 Jan; 39(1):17-22. PubMed ID: 23791154
[TBL] [Abstract][Full Text] [Related]
4. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A injections in children: technique and dosing issues.
Kinnett D
Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S59-64. PubMed ID: 15448579
[TBL] [Abstract][Full Text] [Related]
6. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
McLaughlin MJ; Fisher MT; Vadivelu S; Ramsey J; Ratnasingam D; McGhee E; Hartman K
J Pediatr Rehabil Med; 2020; 13(3):273-279. PubMed ID: 33252098
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
[TBL] [Abstract][Full Text] [Related]
8. Combining botulinum toxin and phenol to manage spasticity in children.
Gooch JL; Patton CP
Arch Phys Med Rehabil; 2004 Jul; 85(7):1121-4. PubMed ID: 15241761
[TBL] [Abstract][Full Text] [Related]
9. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
10. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy].
Klochkova OA; Kurenkov AL; Karimova HM; Namazova-Baranova LS; Memedyarov AM; Kuzenkova LM; Bursagova BI
Vestn Ross Akad Med Nauk; 2014; (9-10):57-63. PubMed ID: 25816644
[TBL] [Abstract][Full Text] [Related]
12. Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?
Sätilä H
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32640636
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin A in children with cerebral palsy.
Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
[TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
Gormley ME; Gaebler-Spira D; Delgado MR
J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
[TBL] [Abstract][Full Text] [Related]
15. Facts and de facto treatment of spasticity.
Kim H; Stanford R
J Pediatr Rehabil Med; 2020; 13(2):189-193. PubMed ID: 32568127
[TBL] [Abstract][Full Text] [Related]
16. [An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy].
Kurenkov AL; Kuzenkova LM; Burgasova BI; Petrova SA; Klochkova OA; Nikitin SS; Artemenko AR; Mamed'iarov AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):53-60. PubMed ID: 23739515
[TBL] [Abstract][Full Text] [Related]
17. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
[TBL] [Abstract][Full Text] [Related]
18. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
20. Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population.
Kazerooni R; Watanabe JH
J Manag Care Spec Pharm; 2021 Apr; 27(4):478-487. PubMed ID: 33511895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
